NEW YORK - Alzheimer's disease patients who are taking a commonly prescribed drug can still benefit from it after they progress to moderate-to-severe illness, when it can be tough to tell whether it's ...

Public Citizen asked the FDA to ban high-dose Aricept because of side effects. May 19, 2011— -- Public Citizen has petitioned the Food and Drug Administration to ban high doses of the Alzheimer's ...

For decades, dementia, especially Alzheimer’s disease, was treated as untouchable. Families watched loved ones fade, doctors could offer only reassurance and coping strategies, and research seemed to ...

July 27, 2010 — The US Food and Drug Administration (FDA) has approved donepezil HCl 23-mg tablets (Aricept; Eisai, Inc and Pfizer, Inc) for the once-daily treatment of moderate to severe Alzheimer's ...

NEW YORK — Alzheimer’s disease patients taking the commonly prescribed drug Aricept can benefit from it after they progress to moderate-to-severe illness, a new study says. The study also found some ...

Anavex (AVXL) blarcamesine faces uncertain FDA path in early Alzheimer’s; Phase 3 may be needed. Read here a detailed ...